Agile Therapeutics, Inc.

0.58 USD
+0.24 (+70.59%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Agile Therapeutics, Inc. stock is up 56.76% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 27.27% of the previous 10 June’s closed higher than May.

About Agile Therapeutics, Inc.

Agile Therapeutics, Inc. researches, develops, and commercializes prescription contraceptive products. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of line extensions and other products.